Inventor · disambiguated record
Timothy Caldwell
Also filed as: CALDWELL TIMOTHY · CALDWELL TIMOTHY M · CALDWELL TIMOTHY MALCOLM
20 granted patents·14 pending applications·530 citations·filing 2002–2024
96Inventor score
Files withDECIPHERA PHARMACEUTICALS LLC16NEUROGEN CORP15LIGAND PHARM INC1UNIV SAINT LOUIS1XU YUELIAN1
Top patents by PatentIndex Score
34 records- 0197US11590134B2Aminopyrimidine amide autophagy inhibitors and methods of use thereofDECIPHERA PHARMACEUTICALS LLC·Filed 2020·Granted Feb 28, 2023·19 cites·20 claims
- 0297US11530206B2Phenylaminopyrimidine amide autophagy inhibitors and methods of use thereofDECIPHERA PHARMACEUTICALS LLC·Filed 2020·Granted Dec 20, 2022·20 cites·37 claims
- 0397US11518758B2Heteroarylaminopyrimidine amide autophagy inhibitors and methods of use thereofDECIPHERA PHARMACEUTICALS LLC·Filed 2020·Granted Dec 6, 2022·16 cites·20 claims
- 0497US9309224B2N-acyl-N′-(pyridin-2-yl) ureas and analogs exhibiting anti-cancer and anti-proliferative activitiesDECIPHERA PHARMACEUTICALS LLC·Filed 2014·Granted Apr 12, 2016·60 cites·40 claims
- 0597US9187474B2Raf inhibitor compoundsDECIPHERA PHARMACEUTICALS LLC·Filed 2013·Granted Nov 17, 2015·60 cites·19 claims
- 0696US9193719B21,2,4-triazol-5-ones and analogs exhibiting anti-cancer and anti-proliferative activitiesDECIPHERA PHARMACEUTICALS LLC·Filed 2014·Granted Nov 24, 2015·60 cites·36 claims
- 0796US9181223B22-aminopyrimidin-6-ones and analogs exhibiting anti-cancer and anti-proliferative activitiesDECIPHERA PHARMACEUTICALS LLC·Filed 2014·Granted Nov 10, 2015·62 cites·29 claims
- 0896US9133183B2Imidazolidinones and analogs exhibiting anti-cancer and anti-proliferative activitiesDECIPHERA PHARMACEUTICALS LLC·Filed 2014·Granted Sep 15, 2015·60 cites·32 claims
- 0995US9382228B2N-acyl-N′-(pyridin-2-yl) ureas and analogs exhibiting anti-cancer and anti-proliferative activitiesDECIPHERA PHARMACEUTICALS LLC·Filed 2014·Granted Jul 5, 2016·60 cites·43 claims
- 1093US7074799B2Substituted quinazolin-4-ylamine analoguesNEUROGEN CORP·Filed 2003·Granted Jul 11, 2006·48 cites·59 claims
- 1188US7304059B2Substituted quinazolin-4-ylamine analoguesNEUROGEN CORP·Filed 2006·Granted Dec 4, 2007·10 cites·58 claims
- 1284US7488740B2Substituted quinolin-4-ylamine analoguesNEUROGEN CORP·Filed 2004·Granted Feb 10, 2009·17 cites·48 claims
- 1382US7935702B2Substituted biaryl quinolin-4-ylamine analoguesNEUROGEN CORP·Filed 2005·Granted May 3, 2011·6 cites·10 claims
- 1481US7432275B2Carboxylic acid, phosphate or phosphonate substituted quinazolin-4-ylamine analogues as capsaicin receptor modulatorsNEUROGEN CORP·Filed 2003·Granted Oct 7, 2008·18 cites·22 claims
- 1580US2025084073A1Phenylaminopyrimidine amide autophagy inhibitors and methods of use thereofDECIPHERA PHARMACEUTICALS LLC·Filed 2024·Application pending·0 cites
- 1679US6953801B2Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analoguesNEUROGEN CORP·Filed 2002·Granted Oct 11, 2005·11 cites·30 claims
- 1775US7851474B2Dipiperazinyl ketones and related analoguesNEUROGEN CORP·Filed 2006·Granted Dec 14, 2010·3 cites·22 claims
- 1874US12377097B2Aminopyrimidine amide autophagy inhibitors and methods of use thereofDECIPHERA PHARMACEUTICALS LLC·Filed 2023·Granted Aug 5, 2025·0 cites·14 claims
- 1973US12071432B2Phenylaminopyrimidine amide autophagy inhibitors and methods of use thereofDECIPHERA PHARMACEUTICALS LLC·Filed 2022·Granted Aug 27, 2024·0 cites·28 claims
- 2069US12479833B2Heteroarylaminopyrimidine amide autophagy inhibitors and methods of use thereofDECIPHERA PHARMACEUTICALS LLC·Filed 2022·Granted Nov 25, 2025·0 cites·30 claims
- 2160US2024150368A1Ulk inhibitors and methods of use thereofDECIPHERA PHARMACEUTICALS LLC·Filed 2023·Application pending·0 cites
- 2260US2008015183A1Substituted quinazolin-4-ylamine analoguesNEUROGEN CORP·Filed 2007·Application pending·0 cites
- 2359US2009286767A1Substituted quinolin-4-ylamine analoguesNEUROGEN CORP·Filed 2009·Application pending·0 cites
- 2456US7241765B2Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analoguesNEUROGEN CORP·Filed 2006·Granted Jul 10, 2007·0 cites·44 claims
- 2556US2024116877A1Kit kinase inhibitors and methods of use thereofDECIPHERA PHARMACEUTICALS LLC·Filed 2022·Application pending·0 cites
- 2649US2016046619A1Imidazolidinones and analogs exhibiting anti-cancer and anti-proliferative activitiesDECIPHERA PHARMACEUTICALS LLC·Filed 2015·Application pending·0 cites
- 2749US2011002855A1Piperazinyl oxoalkyl tetrahydro-beta-carbolines and related analoguesNEUROGEN CORP·Filed 2008·Application pending·0 cites
- 2846US2008247964A1Substituted azaspiro derivativesXU YUELIAN·Filed 2007·Application pending·0 cites
- 2944US2008085901A1Heteroaryl Substituted Quinolin-4-Ylamine AnaloguesNEUROGEN CORP·Filed 2006·Application pending·0 cites
- 3044US2011082130A1Piperazinyl oxoalkyl tetrahydroisoquinolines and related analoguesLIGAND PHARM INC·Filed 2010·Application pending·0 cites
- 3144US2008175794A1Substituted Pyridazinyl- and Pyrimidinyl-Quinolin-4-Ylamine AnaloguesNEUROGEN CORP·Filed 2006·Application pending·0 cites
- 3243US2006194805A1Capsaicin receptor agonistsNEUROGEN CORP·Filed 2006·Application pending·0 cites
- 3342US2022079951A1Bet inhibitors for modulating dux4 expression in fshdUNIV SAINT LOUIS·Filed 2019·Application pending·0 cites
- 3442US2007203133A1Substituted 5,12-diaza-benzoanthracene analoguesNEUROGEN CORP·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Timothy Caldwell files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →